Article Versions Notes

Nowotny HF, Choi H, Ziegler S, Doll N, Bäuerle A, Welp A-C, Dubinski I, Schiergens K, Neumann U, Tschaidse L, et al. Immunophenotypic Implications of Reverse-Circadian Glucocorticoid Treatment in Congenital Adrenal Hyperplasia. International Journal of Molecular Sciences. 2025; 26(4):1479. https://doi.org/10.3390/ijms26041479

Nowotny, Hanna F., Hannah Choi, Selina Ziegler, Natalie Doll, Ariane Bäuerle, Ann-Christin Welp, Ilja Dubinski, Katharina Schiergens, Uta Neumann, Lea Tschaidse, and et al. 2025. "Immunophenotypic Implications of Reverse-Circadian Glucocorticoid Treatment in Congenital Adrenal Hyperplasia" International Journal of Molecular Sciences 26, no. 4: 1479. https://doi.org/10.3390/ijms26041479

Nowotny, H. F., Choi, H., Ziegler, S., Doll, N., Bäuerle, A., Welp, A.-C., Dubinski, I., Schiergens, K., Neumann, U., Tschaidse, L., Auer, M. K., Rothenfusser, S., Schmidt, H., & Reisch, N. (2025). Immunophenotypic Implications of Reverse-Circadian Glucocorticoid Treatment in Congenital Adrenal Hyperplasia. International Journal of Molecular Sciences, 26(4), 1479. https://doi.org/10.3390/ijms26041479